MittalA.ColegioOR. Skin cancers in organ transplant recipients. Am J Transplant. 2017;17(10):2509-2530.doi:10.1111/ajt.14382http://www.ncbi.nlm.nih.gov/pubmed/28556451
2.
ChenAC.MartinAJ.ChoyBet al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618-1626.doi:10.1056/NEJMoa1506197http://www.ncbi.nlm.nih.gov/pubmed/26488693
3.
DragoF.CiccareseG.CogornoL.CalviC.MarsanoLA.ParodiA. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol. 2017;27(4):382-385.doi:10.1684/ejd.2017.3025http://www.ncbi.nlm.nih.gov/pubmed/28468736
4.
MinochaR.MartinAJ.ChenACet al. A reduction in inflammatory macrophages may contribute to skin cancer chemoprevention by nicotinamide. J Invest Dermatol. 2019;139(2):467-469.doi:10.1016/j.jid.2018.08.018http://www.ncbi.nlm.nih.gov/pubmed/30244097
5.
NikasIP.PaschouSA.RyuHS. The role of nicotinamide in cancer chemoprevention and therapy. Biomolecules. 2020;10(3):477doi:10.3390/biom1003047732245130
6.
HosseiniB. Vitamin B3–Not all forms are equivalent!Journal of Pharmacy Practice and Research. 2017;47(1):79-80.doi:10.1002/jppr.1250
